Funded Startups in Mont-saint-guibert
Six funded rounds are listed for Mont-saint-guibert, spanning from 2022-11-03 (Novadip Biosciences) to 2026-06-17 (Nyxoah).
Six funded rounds are listed for Mont-saint-guibert, spanning from 2022-11-03 (Novadip Biosciences) to 2026-06-17 (Nyxoah). The largest disclosed amount is Novadip Biosciences’ $23M round on 2022-11-03, and it stands above the rest of the disclosed figures: the next-largest is $19M (e-peas on 2024-03-20) while $17M (Cognivia, 2024-04-18), $15M (Nyxoah, 2026-06-17), and $10M (Celyad, 2023-08-24) sit further down.
The entries cluster heavily by sector and stage label: all six companies are in Biotechnology except e-peas in Consumer Electronics, and five of the six rounds show “Series Unknown” (Nyxoah 2026-06-17, Cognivia 2024-04-18, e-peas 2024-03-20, Celyad 2023-08-24, plus one more Series Unknown entry). By timing, there is a mid-window concentration from 2023-08-24 through 2024-04-18, where four of the six rounds land between 2023-08-24 and 2024-04-18.
Most recent rounds
6 shownRelated listings
Frequently asked
What is the largest disclosed round in this Mont-saint-guibert set, and is it an outlier versus the rest?
Novadip Biosciences’ $23M on 2022-11-03 is the largest disclosed amount; the next-highest disclosed round is $19M (e-peas, 2024-03-20). The remaining disclosed amounts step down to $17M (Cognivia, 2024-04-18), $15M (Nyxoah, 2026-06-17), $10M (Celyad, 2023-08-24), and $2M (EsoBiotec, 2023-12-12).
Are these rounds clustered in time, or spread out evenly across the period shown?
They are not evenly spread: four of the six rounds fall between 2023-08-24 (Celyad) and 2024-04-18 (Cognivia). Outside that window, the list includes older activity at 2022-11-03 (Novadip Biosciences) and a later jump to 2026-06-17 (Nyxoah).
How concentrated is sector representation in this city list?
Biotechnology dominates: five of six companies are listed as Biotechnology (Nyxoah, Cognivia, EsoBiotec, Celyad, Novadip Biosciences). The only non-biotech entry is e-peas, categorized as Consumer Electronics, with a $19M round on 2024-03-20.
What stage labels dominate, and which rounds provide the exceptions?
“Series Unknown” appears in five of the six entries (Nyxoah $15M on 2026-06-17; Cognivia $17M on 2024-04-18; e-peas $19M on 2024-03-20; Celyad $10M on 2023-08-24; and one additional “Series Unknown” row in the same set). The exceptions are EsoBiotec with Series A ($2M on 2023-12-12) and Novadip Biosciences with Series B ($23M on 2022-11-03).
Which entries look most like outliers by disclosed amount?
EsoBiotec’s $2M on 2023-12-12 is the low-end outlier versus the rest of the disclosed amounts ($10M to $23M across Celyad 2023-08-24, e-peas 2024-03-20, Cognivia 2024-04-18, Nyxoah 2026-06-17, and Novadip Biosciences 2022-11-03). On the high end, Novadip Biosciences’ $23M on 2022-11-03 is the top disclosed figure, ahead of the rest of the cluster.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.